# RECURSION PHARMACEUTICALS, INC.: Form D filings

RECURSION PHARMACEUTICALS, INC., a pharmaceuticals company in Salt Lake City, UT, filed 12 Form D notices with the SEC between 2014 and 2020. The latest, on November 12, 2020, reports $245.9 million sold of a $245.9 million offering to 49 investors.

Find out what RECURSION PHARMACEUTICALS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20RECURSION%20PHARMACEUTICALS%2C%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=RECURSION%20PHARMACEUTICALS%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Frecursion-pharmaceuticals-inc-1601830)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20RECURSION%20PHARMACEUTICALS%2C%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=RECURSION%20PHARMACEUTICALS%2C%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Frecursion-pharmaceuticals-inc-1601830)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Utah](https://specstream.ai/data/form-d/state/utah): 660 rows, by operating companies, filed since November 1, 2024, $33, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/utah
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 41S RIO GRANDE STREET, Salt Lake City, UT, 84101
- Phone: (385) 269-0203
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1601830

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 12, 2020 | Amendment | $245,896,677 | $245,896,677 | $0 | 49 | Sep 1, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1601830/000160183020000002/0001601830-20-000002-index.htm) |
| Sep 15, 2020 | New notice | $235,506,731 | $235,506,731 | $0 | 38 | Sep 1, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1601830/000160183020000001/0001601830-20-000001-index.htm) |
| Aug 13, 2019 | New notice | $122,057,689 | $122,057,689 | $0 | 33 | Feb 12, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1601830/000160183019000002/0001601830-19-000002-index.htm) |
| Oct 6, 2017 | New notice | $59,999,975 | $55,799,946 | $4,200,029 | 26 | Sep 25, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1601830/000160183017000003/0001601830-17-000003-index.htm) |
| Dec 2, 2016 | Amendment | $15,034,984 | $15,034,984 | $0 | 18 | Sep 2, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1601830/000160183016000008/0001601830-16-000008-index.htm) |
| Sep 14, 2016 | New notice | $12,909,987 | $12,909,987 | $0 | 13 | Sep 2, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1601830/000160183016000007/0001601830-16-000007-index.htm) |
| Sep 14, 2016 | New notice | $32,000,000 | $32,000,000 | $0 | 32 | Sep 1, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1601830/000160183016000006/0001601830-16-000006-index.htm) |
| Sep 14, 2016 | New notice | $4,066,996 | $4,066,996 | $0 | 31 | Sep 1, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1601830/000160183016000005/0001601830-16-000005-index.htm) |
| Dec 4, 2015 | New notice | $2,700,000 | $2,650,000 | $50,000 | 8 | Nov 20, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1601830/000160183015000002/0001601830-15-000002-index.htm) |
| Feb 23, 2015 | New notice | $1,000,000 | $830,000 | $170,000 | 19 | Feb 17, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1601830/000160183015000001/0001601830-15-000001-index.htm) |
| Apr 2, 2014 | Amendment | $200,000 | $80,000 | $120,000 | 5 | Mar 19, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1601830/000160183014000004/0001601830-14-000004-index.htm) |
| Apr 2, 2014 | New notice | $200,000 | $80,000 | $120,000 | 5 | Mar 19, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1601830/000160183014000002/0001601830-14-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| ROBERT C. HERSHBERG | Director |  |
| R. MARTIN CHAVEZ | Director |  |
| MICHAEL MARTIN SECORA | Executive Officer, Promoter |  |
| DEAN C. LI | Director |  |
| ZACHARY C. BOGUE | Director |  |
| ZAVAIN C. DAR | Director |  |
| BLAKE C. BORGESON | Director |  |
| CHRISTOPHER C. GIBSON | Executive Officer, Director, Promoter |  |
| TERRY-ANN C. BURRELL | Director |  |

[Every Form D from the week of Nov 9, 2020](https://specstream.ai/data/form-d/week/2020-11-09) · [All recent filings in Utah](https://specstream.ai/data/form-d/state/utah) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what RECURSION PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).